Intracellular Regulation of Fas-Induced Apoptosis in Human Fibroblasts by Extracellular Factors and Cycloheximide

Journal of Immunology

Volumn 172, Issue 1, 2004, Pages 560-566

  Santiago, Begoña ^a   Galindo, María ^a   Palao, Guillermo ^a   Pablos, José L ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CYCLOHEXIMIDE; CYTOKINE; FAS ANTIGEN; FLICE INHIBITORY PROTEIN;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUSPENSION CELL CULTURE; TH1 CELL;

EID: 0347994946     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.1.560     Document Type: Article

References (52)

1. Pablos, J. L., P. E. Carreira, L. Serrano, P. Del Castillo, and J. J. Gomez-Reino. 1997. Apoptosis and proliferation of fibroblasts during postnatal skin development and scleroderma in the tight-skin mouse. J. Histochem. Cytochem. 45:711.
2. Desmoulière, A., M. Redar, I. Darby, and G. Gabbiani. 1995. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am. J. Pathol. 146:56.
3. Iredale, J. P., R. C. Benyon, J. Pickering, M. McCullen, M. Northrop, S. Pawley, C. Hovell, and M. J. Arthur. 1998. Mechanisms of spontaneous resolution of rat liver fibrosis: hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J. Clin. Invest. 102:538.
4. Santiago, B., M. Galindo, M. Rivero, and J. L. Pablos. 2001. Decreased susceptibility to Fas-induced apoptosis of systemic sclerosis DF. Arthritis Rheum. 44:1667.
5. Chodon, T., T. Sugihara, H. H. Igawa, E. Funayama, and H. Furukawa. 2000. Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-β1 can abrogate this resistance. Am. J. Pathol. 157:1661.
6. Jelaska, A., and J. H. Korn. 2000. Role of apoptosis and transforming growth factor β1 in fibroblast selection and activation in systemic sclerosis. Arthritis Rheum. 43:2230.
7. Fluck, J., C. Querfeld, A. Cremer, S. Niland, T. Krieg, and S. Sollberg. 1998. Normal human primary fibroblasts undergo apoptosis in three-dimensional contractile collagen gels. J. Invest. Dermatol. 110:153.
8. Kirk, T. Z., and M. D. Mayes. 1999. IL-1 rescues scleroderma myofibroblasts from serum-starvation-induced cell death. Biochem. Biophys. Res. Commun. 255:129.
9. Lee, C. G., R. J. Homer, L. Cohn, H. Link, S. Jung, J. E. Craft, B. S. Graham, T. R. Johnson, and J. A. Elias. 2002. Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways. J. Biol. Chem. 277:35466.
10. Louis, H., A. Le Moine, E. Quertinmont, M. O. Peny, A. Geerts, M. Goldman, O. Le Moine, and J. Deviere. 2000. Repeated concanavalin A challenge in mice induces an interleukin 10-producing phenotype and liver fibrosis. Hepatology 31:381.
11. Ziesche, R., E. Hofbauer, K. Wittmann, V. Petkov, and L. H. Block. 1999. A preliminary study of long-term treatment with interferon γ-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 341:1264.
12. Sanderson, N., V. Factor, P. Nagy, J. Kopp, P. Kondaiah, L. Wakefield, A. B. Roberts, M. B. Sporn, and S. S. Thorgeirsson. 1995. Hepatic expression of mature transforming growth factor β1 in transgenic mice results in multiple tissue lesions. Proc. Natl. Acad. Sci. USA 92:2572.
13. Abraham, D. J., X. Shiwen, C. M. Black, S. Sa, Y. Xu, and A. Leask. 2000. Tumor necrosis factor a suppresses the induction of connective tissue growth factor by transforming growth factor-β in normal and scleroderma fibroblasts. J. Biol. Chem. 275:15220.
14. Scharffetter, K., M. Heckmann, A. Hatamochi, C. Mauch, B. Stein, G. Riethmuller, H. W. Ziegler-Heitbrock, and T. Krieg. 1989. Synergistic effect of tumor necrosis factor-α and interferon-γ on collagen synthesis of human skin fibroblasts in vitro. Exp. Cell Res. 181:409.
15. Kahari, V. M., Y. Q. Chen, M. W. Su, F. Ramirez, and J. Uitto. 1990. Tumor necrosis factor-α and interferon-γ suppress the activation of human type 1 collagen gene expression by transforming growth factor-β1: evidence for two distinct mechanisms of inhibition at the transcriptional and posttranscriptional levels. J. Clin. Invest. 86:1489.
16. Medema, J. P., C. Scaffidi, F. C. Kischkel, A. Shevchenko, M. Mann, P. H. Krammer, and M. E. Peter. 1997. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16:2794.
17. Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, F. Li, K. J. Tomaselli, K. M. Debatin, P. H. Krammer, and M. E. Peter. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17:1675.
18. Perlman, H., L. J. Pagliari, C. Georganas, T. Mano, K. Walsh, and R. M. Pope. 1999. FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis. J. Exp. Med. 190:1679.
19. Poulaki, V., C. S. Mitsiades, V. Kotoula, S. Tseleni-Balafouta, A. Ashkenazi, D. A. Koutras, and N. Mitsiades. 2002. Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells. Am. J. Pathol. 161:643.
20. Kreuz, S., D. Siegmund, P. Scheurich, and H. Wajant. 2001. NF-κB inducers up-regulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol. Cell. Biol. 21:3964.
21. Thome, M., and J. Tschopp. 2001. Regulation of lymphocyte proliferation and dedth-by FLIP. Nat. Rev. Immunol. 1:50.
22. Irmler, M., M. Thome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J. L. Bodmer, M. Schroter, K. Burns, C. Mattmann, et al. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388:190.
23. Chang, D. W., Z. Xing, Y. Pan, A. Algeciras-Schimnich, B. C. Barnhart, S. Yaish-Ohad, M. E. Peter, and X. Yang. 2002. c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J. 21:3704.
24. Yeh, W. C., A. Itie, A. J. Elia, M. Ng, H. B. Shu, A. Wakeham, C. Mirtsos, N. Suzuki, M. Bonnard, D. V. Goeddel, and T. W. Mak. 2000. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 12:633.
25. Nakajima, M., A. Nakajima, N. Kayagaki, M. Honda, H. Yagita, and K. Okumura. 1997. Expression of Fas ligand and its receptor in cutaneous lupus: implication in tissue injury. Clin. Immunol. Immunopathol. 83:223.
26. Aggarwal, B. B., S. Singh, R. LaPushin, and K. Totpal. 1995. Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor. FEBS Lett. 364:5.
27. Freiberg, R. A., D. M. Spencer, K. A. Choate, H. J. Duh, S. L. Schreiber, G. R. Crabtree, and P. A. Khavari. 1997. Fas signal transduction triggers either proliferation or apoptosis in human fibroblasts. J. Invest. Dermatol. 108:215.
28. Ahn, J., H. S. M. Park, H. S. Cho, M. S. Lee, J. B. Yoon, J. Vilcek, and T. H. Lee. 2001. Non-apoptotic signaling pathways activated by soluble Fas ligand in serum-starved human fibroblasts: mitogen-activated protein kinases and NF-κB-dependent gene expression. J. Biol. Chem. 276:47100.
29. Wajant, H., E. Haas, R. Schwenzer, F. Muhlenbeck, S. Kreuz, G. Schubert, M. Grell, C. Smith, and P. Scheurich. 2000. Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD). J. Biol. Chem. 275:24357.
30. Ogasawara, J., R. Watanabe-Fukuhaga, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. 1993. Lethal effect of the anti-Fas antibody in mice. Nature 364:806.
31. Janin, A., C. Deschaumes, M. Daneshpouy, J. Estaquier, J. Micic-Polianski, P. Rajagopalan-Levasseur, K. Akarid, N. Mounier, E. Gluckman, G. Socie, and J. C. Ameisen. 2002. CD95 engagement induces disseminated endothelial cell apoptosis in vivo: immunopathologic implications. Blood 99:2940.
32. Gonzalez-Cuadrado, S., C. Lorz, R. Garcia del Moral, F. O'Valle, C. Alonso, F. Ramiro, A. Ortiz-Gonzalez, J. Egido, and A. Ortiz. 1997. Agonistic anti-Fas antibodies induce glomerular cell apoptosis in mice in vivo. Kidney Int. 51:1739.
33. Matute-Bello, G., R. K. Winn, M. Jonas, E. Y. Chi, T. R. Martin, and W. C. Liles. 2001. Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: implications for acute pulmonary inflammation. Am. J. Pathol. 158:153.
34. Saile, B., T. Knittel, N. Matthes, P. Schott, and G. Ramadori. 1997. CD95/CD95L-mediated apoptosis of the hepatic stellate cell: a mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair. Am. J. Pathol. 151:1265.
35. Okamoto, K., H. Asahara, T. Kobayashi, H. Matsuno, T. Hasunuma, T. Kobata, T. Sumida, and K. Nishioka. 1998. Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer. Gene Ther. 5:331.
36. Kataoka, T., R. C. Budd, N. Holler, M. Thome, F. Martinon, M. Irmler, K. Burns, M. Hahne, N. Kennedy, M. Kovacsovics, and J. Tschopp. 2000. The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways. Curr. Biol. 10:640.
37. Hu, W. H., H. Johnson, and H. B. Shu. 2000. Activation of NF-κB by FADD, Casper, and caspase-8. J. Biol. Chem. 275:10838.
38. Micheau, O., M. Thome, P. Schneider, N. Holler, J. Tschopp, D. Nicholson, C. Briand, and M. G. Grutter. 2002. The long form of FLIP is an activator of Caspase-8 at the Fas death-inducing signaling complex. J. Biol. Chem. 277:45162.
39. Nagaraju, K., L. Casciola-Rosen, A. Rosen, C. Thompson, L. Loeffler, T. Parker, C. Danning, P. J. Rochon, J. Gillespie, and P. Plotz. 2000. The inhibition of apoptosis in myositis and in normal muscle cells. J. Immunol. 164:5459.
40. Yoshikawa, H., Y. Nakajima, and K. Tasaka. 2000. Enhanced expression of Fas-associated death domain-like IL-1-converting enzyme (FLICE)-inhibitory protein induces resistance to Fas-mediated apoptosis in activated mast cells. J. Immunol. 165:6262.
41. Hyer, M. L., S. Sudarshan, Y. Kim, J. C. Reed, J. Y. Dang, D. A. Schwartz, and J. S. Norris. 2002. Down-regulation of c-FLIP sensitizes DU145 prostate cancer cells to Fas-mediated apoptosis. Cancer Biol. Ther. 1:401.
42. Fulda, S., and K. M. Debatin. 2002. IFNγ sensitizes for apoptosis by up-regulating caspase-8 expression through the Stat1 pathway. Oncogene 21:2295.
43. Refaeli, Y., L. Van Parijs S. I. Alexander and A. K. Abbas. 2002. Interferon γ is required for activation-induced death of T lymphocytes. J. Exp. Med. 196:999.
44. Chen, S., D. C. Guttridge, E. Tang, S. Shi, K. Guan, and C. Y. Wang. 2001. Suppression of tumor necrosis factor-mediated apoptosis by nuclear factor κB-independent bone morphogenetic protein/Smad, signaling. J. Biol. Chem. 276:39259.
45. Li, J. H., M. S. Kluger, L. A. Madge, L. Zheng, A. L. Bothwell, and S. J. Pober, 2002. Interferon-γ augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis Am. J. Pathol. 161:1485.
46. Bretz, J. D., P. L. Arscott, A. Myc, and J. R.-Baker, Jr. 1999. Inflammatory cytokine regulation of Fas-mediated apoptosis in thyroid follicular cells. J. Biol. Chem. 274:25433.
47. Letterio, J. J., and A. B. Roberts. 1998. Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 16:137.
48. Hogaboam C. M., C. L. Bone-Larson, S. Lipinski, N. W. Lukacs, S. W. Chensue, R. M. Strieter, and S. L. Kunkel. 1999. Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models. J. Immunol. 163:2193.
49. Wahl, S. M., M. Frazier-Jessen, W. W. Jin, J. B. Kopp, A. Sher, and A. W. Cheever. 1997. Cytokine regulation of schistosome-induced granuloma and fibrosis. Kidney Int. 51:1370.
50. Castilla, A., J. Prieto, and N. Fausto. 1991. Transforming growth factors β1 and α in chronic liver disease: effects of interferon a therapy. N Engl J Med. 324:933.
51. Yamamoto, T., B. Eckes, and T. Krieg. 2001. Effect of interleukin-10 on the gene expression of type 1 collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-β and monocyte chemoattractant protein-1. Biochem. Biophys. Res. Commun. 281:200.
52. Jelaska, A., M. Arakawa, G. Broketa, and J. H. Korn. 1996. Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts: increased proportion of high collagen-producing cells in systemic sclerosis fibroblasts. Arthritis Rheum. 39:1338.